Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal
Cancer
Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die. Giving the drugs directly into the tumor after surgery
and combining them with radiation therapy may kill more tumor cells. This is a Phase
II trial to study the effectiveness of combining surgery, chemotherapy, and radiation
therapy in treating patients who have peritoneal cancer.
Objectives:
Determine the response rate, duration of response, and duration of survival of patients
with peritoneal mesothelioma treated with surgery, intraperitoneal chemotherapy,
and whole abdominal radiotherapy.
Location and Contact Information:
New York
Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States;
Recruiting
Mary Louise Keohan, MD 212-305-0592
Study chairs or principal investigators
Robert N. Taub, MD, PhD, Study Chair
Columbia Presbyterian Medical Center
